rs11653796 - ACBD4

Magnitude 2.2 · 2 studies on file

Reported associations

  • Genetic drivers of heterogeneity in type 2 diabetes pathophysiology - Unknown journal (n.d.) · Unknown authors · PubMed 38374256

    ABSTRACT: Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes and molecular mechanisms that are often specific to cell type. Here, to characterize the genetic contribution to these processes across ancestry groups, we aggregate genome-wide association study data from 2,535,601 individuals (39.7% not of European ancestry), including 428,452 cases of T2D. We identify 1,289 independent association signals at genome-wide significance (P < 5 × 10−8) that map to 611 loci, of which 145 loci are, to our knowledge, previously unreported. We define eight non-overlapping clusters of T2D signals that are characterized by distinct profiles of cardiometabolic trait associations. These clusters are differentially enriched for cell-type-sp

  • Participation bias in the UK Biobank distorts genetic associations and downstream analyses - Unknown journal (n.d.) · Unknown authors · PubMed 37106081

    ABSTRACT: While volunteer-based studies such as the UK Biobank have become the cornerstone of genetic epidemiology, the participating individuals are rarely representative of their target population. To evaluate the impact of selective participation, here we derived UK Biobank participation probabilities on the basis of 14 variables harmonized across the UK Biobank and a representative sample. We then conducted weighted genome-wide association analyses on 19 traits. Comparing the output from weighted genome-wide association analyses (neffective = 94,643 to 102,215) with that from standard genome-wide association analyses (n = 263,464 to 283,749), we found that increasing representativeness led to changes in SNP effect sizes and identified novel SNP associations for 12 traits. While


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • Type 2 diabetes risk and screening strategy Moderate

    Genome-wide significant association suggests discussing personalized risk assessment with healthcare provider.

    Review individual diabetes risk factors and recommended screening intervals with physician.

Exercise

  • regular aerobic and resistance exercise Moderate

    Physical activity improves insulin sensitivity and is protective against Type 2 diabetes.

    Aim for 150+ minutes moderate-intensity aerobic exercise and 2 sessions resistance training weekly.

Lifestyle

  • weight management Moderate

    Maintaining healthy weight reduces Type 2 diabetes risk independent of genetic factors.

    Target BMI 18.5-24.9 kg/m2; monitor weight trends regularly.

Screening

  • fasting glucose and HbA1c Moderate

    ACBD4 rs11653796 G allele associated with increased Type 2 diabetes risk (GWAS p=5e-8, n=2.5M).

    Annual fasting glucose and HbA1c screening; discuss frequency with provider.